Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: METASTATIC BREAST CANCER (MBC), . Treffer: 10
2021
Aftimos, P; Oliveira, M; Irrthum, A; Fumagalli, D; Sotiriou, C; Gal-Yam, EN; Robson, ME; Ndozeng, J; Di, Leo, A; Ciruelos, EM; de, Azambuja, E; Viale, G; Scheepers, ED; Curigliano, G; Bliss, JM; Reis-Filho, JS; Colleoni, M; Balic, M; Cardoso, F; Albanell, J; Duhem, C; Marreaud, S; Romagnoli, D; Rojas, B; Gombos, A; Wildiers, H; Guerrero-Zotano, A; Hall, P; Bonetti, A; Larsson, KF; Degiorgis, M; Khodaverdi, S; Greil, R; Sverrisdóttir, Á; Paoli, M; Seyll, E; Loibl, S; Linderholm, B; Zoppoli, G; Davidson, NE; Johannsson, OT; Bedard, PL; Loi, S; Knox, S; Cameron, DA; Harbeck, N; Montoya, ML; Brandão, M; Vingiani, A; Caballero, C; Hilbers, FS; Yates, LR; Benelli, M; Venet, D; Piccart, MJ
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
Cancer Discov. 2021; 11(11): 2796-2811.
Doi: 10.1158/2159-8290.CD-20-1647
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gampenrieder, SP; Rinnerthaler, G; Tinchon, C; Petzer, A; Balic, M; Heibl, S; Schmitt, C; Zabernigg, AF; Egle, D; Sandholzer, M; Singer, CF; Roitner, F; Hager, C; Andel, J; Hubalek, M; Knauer, M; Greil, R
Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry.
BREAST CANCER RES. 2021; 23(1): 112
Doi: 10.1186/s13058-021-01492-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Hubalek, M; Petru, E; Sandholzer, M; Andel, J; Balic, M; Melchardt, T; Hauser-Kronberger, C; Schmitt, CA; Ulmer, H; Greil, R
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6).
Ther Adv Med Oncol. 2021; 13: 17588359211042301
Doi: 10.1177/17588359211042301
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Bourrier, C; Pierga, JY; Xuereb, L; Salaun, H; Proudhon, C; Speicher, MR; Belic, J; Heitzer, E; Lockhart, BP; Guigal-Stephan, N
Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival.
Cancers (Basel). 2020; 12(6):
Doi: 10.3390/cancers12061481
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2019
Cazzaniga, ME; Munzone, E; Bocci, G; Afonso, N; Gomez, P; Langkjer, S; Petru, E; Pivot, X; Sánchez Rovira, P; Wysocki, P; Torri, V
Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project.
ADV THER. 2019; 36(2): 381-406.
Doi: 10.1007/s12325-018-0844-4
Web of Science
PubMed
FullText
FullText_MUG
Suppan, C; Brcic, I; Tiran, V; Mueller, HD; Posch, F; Auer, M; Ercan, E; Ulz, P; Cote, RJ; Datar, RH; Dandachi, N; Heitzer, E; Balic, M
Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment.
Cancers (Basel). 2019; 11(8):
Doi: 10.3390/cancers11081171
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Schramm, A; Friedl, TW; Schochter, F; Scholz, C; de Gregorio, N; Huober, J; Rack, B; Trapp, E; Alunni-Fabbroni, M; Müller, V; Schneeweiss, A; Pantel, K; Meier-Stiegen, F; Hartkopf, A; Taran, FA; Wallwiener, D; Janni, W; Fehm, T
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
Arch Gynecol Obstet. 2016; 293(2):271-281
Doi: 10.1007/s00404-015-3879-7
Web of Science
PubMed
FullText
FullText_MUG
2015
Pircher, M; Mlineritsch, B; Fridrik, MA; Dittrich, C; Lang, A; Petru, E; Weltermann, A; Thaler, J; Hufnagl, C; Gampenrieder, SP; Rinnerthaler, G; Ressler, S; Ulmer, H; Greil, R
Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial.
Anticancer Res. 2015; 35(1):517-521
Web of Science
PubMed
2014
Regierer, AC; Wolters, R; Ufen, MP; Weigel, A; Novopashenny, I; Köhne, CH; Samonigg, H; Eucker, J; Possinger, K; Wischnewsky, MB
An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients.
Ann Oncol. 2014; 25(3):633-638
Doi: 10.1093/annonc/mdt539
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2003
Paridaens, R; Van Aelst, F; Georgoulias, V; Samonigg, H; Cocquyt, V; Zielinski, C; Hausmaninger, H; Willemse, P; Boudraa, Y; Wildiers, J; Ramazeilles, C; Azli, N
A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer.
ANN ONCOL. 2003; 14(3): 433-440.
Doi: 10.1093/annonc/mdg111
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG